Helixgate https://validator.w3.org/feed/docs/rss2.html Ramaswamy’s biotech baggage haunted his political run From gene editing to RNA therapies: The biotech trends to look out for at AHA Scientific Sessions 2026 The biggest biotech funding rounds in October 2026 Patient Advocacy Coffee Chat: Basic steps to being a good advocate BIO responds to Health Affairs Analysis, highlighting the importance of orphan drug incentives Pfizer eyes Europe first for Lyme vaccine as prevalence rises in US With MFN now embedded in pharma, execs see little impact from Democrats’ blue wave Boehringer bets big on China, offering $7B biobucks for Sino cancer programs 1 in 5 have had multiple biopharma layoffs, poll finds Beyond the needle: The future of intratumoral therapy Coveted metabolic gem Rhythm reportedly gets $10B offer from AstraZeneca T-time: British biotech pours $133M into the pot for bispecifics Novartis confirms 9 reported cases of tumors in patients treated with Zolgensma Boehringer forges $7bn alliance with China’s SBP Group UK biotechs T-Therapeutics and Alethio score big financings Bayer’s Hyrnuo moves first-line for lung cancer in China Linking kinase inhibitors for greater selectivity Checkpoint inhibitor combinations: the trial-to-approval gap Degraders take on GPCRs Novartis subsidiary Avidity will lay off 40 in San Diego Pritam International Private Limited – 738079 – 10/27/2026 Opioid Overdose Reversal Medications Medications for Opioid Use Disorder (MOUD) Generic Competition and Drug Prices PDUFA and BsUFA Quarterly Hiring Updates FDA Pediatric Safety Communications STAT+: Former Madrigal Pharmaceuticals executive alleges coverup of safety issues tied to its drug Biopharma likely to climb higher after ‘blue wave,’ analysts say Radiopharma venture money moves toward alpha emitters FDA needs a roadmap for disease-agnostic drug development — a Perspective Caspian: Regenerating beta cells with a menin inhibitor With Vidya acquisition, Gujrathi takes chair role at Processa FDA approves first DNA plasmid immunotherapy; NME tally reaches 47 Molecular imaging reveals how shape-shifting protein complex captures DNA and holds separate sections together AlphaFold 3 predicts complex immune interactions using protein sequences alone STAT+: Pharmalittle: We’re reading about CVS plans to split up, FDA inspections in India and China and more STAT+: Ultragenyx cuts staff after another study fails  STAT+: Pharma critic Bernie Sanders is set to hold major sway over FDA funding bill Standardized Apheresis Processes Would Help Cell Therapy Sector Small Bioprocess Monitoring Hits the Goldilocks Zone Rethinking the Clone-First Paradigm for First-in-Human Biologics HIV-Blocking Antibody Shows Promise, but Resistant Strains Break Through Building Custom DNA without Bacterial Constraints Gene That Preserves Bone Stem Cell Supply Throughout Life Identified As Therapeutic Modalities Expand, Genomic Profiling Must Keep Pace Multiomic Human Glioblastoma Cell Atlas Could Act as Compass to Guide Future Treatment Approaches Lonza Expanding U.S. CDMO Footprint with Purchase of Five Merck KGaA Sites Beyond Outsourcing: Building Better CDMO Partnerships Most nurses at Ugandan hospital miss at least one of the Five Rights of antimicrobial administration, survey finds Home